ADRB2 and breast cancer: In contrast to the theme presented above, Carie et al. [72] have shown that stimulation of the β2-AR resulted in the blockade of the intracellular Raf-1/Mek-1/Erk1/2 pathway, leading to inhibition of growth and survival of human MDA-MB-231 breast cancer cells.